
Pharmaceuticals
Developing innovative medicines for patients, creating value for healthcare providers
Developing innovative medicines for patients, creating value for healthcare providers
Pioneering evidence-based therapies, delivering better access for users
Focusing on areas of great human suffering with wider societal implications
MAY 10, 2022
One Pill Can Kill – Fentanyl Awareness Day May 10
APRIL 28, 2022
Interim Report Q1 - Promising start to 2022
APRIL 27, 2022
Orexo´s partner Gesynta Pharma granted Orphan Drug Designation by the FDA for OX-MPI - systemic sclerosis
Strong history paving the way for the future. Learn more about our key milestones since we where founded in Uppsala, Sweden, in 1995.
Today we look forward to have our CEO Nikolaj Sørensen presenting at @ABGSC Life Science Summit -an event open for… https://t.co/9F4LQgDrzw
According to @CenterOfDisease fatal overdoses increased 15% in 2021. In total >107 000 Americans lost their lives i… https://t.co/L6Q7oSRf12
Today is the first ever National #fentanylawarenessday, set up to draw attention to the growing problem of illicit… https://t.co/a2y76SkSl2
Group net revenues
LTM1
Group EBITDA
LTM1
US Pharma segment EBIT
LTM1
Cash position
Q1 2022
1 Last Twelve Months, Q221-Q122, for more information about financial development Link